Resveratrol is a phytoalexin abundantly found in red grape skin and is effective in antitumor and antiinflammation associated with immune responses. This study investigated whether
resveratrol suppressed
immunoglobulin (Ig)E-mediated allergic responses and passive cutaneous anaphylaxis (PCA) in rat RBL-2H3 mast cells and in BALB/c mice. The release of β-
hexosaminidase and
histamine was enhanced in mast cells sensitized with anti-dinitrophenyl (DNP)-
IgE and subsequently stimulated by DNP-
human serum albumin (HSA), indicative of mast cell degranulation. When mast cells were pretreated with nontoxic
resveratrol at 1-25 μmol/L, such induction was dose dependently diminished.
Spleen tyrosine kinase (Syk) and
phospholipase Cγ (PLCγ) of sensitized mast cells were activated by stimulation with
DNP-HSA antigen, which was dampened by ≥5 μmol/L
resveratrol. The phosphorylation of
protein kinase C (PKC)μ and PKCθ was attenuated by administering
resveratrol to
DNP-HSA-exposed mast cells, whereas quiescent PKCζ/λ in sensitized cells was dose-dependently activated by
resveratrol. Male BALB/c mice were sensitized for 24 h with DNP-
IgE and orally administered with
resveratrol 1 h before the
DNP-HSA challenge. The
histamine concentration was enhanced in sensitized mice challenged to
DNP-HSA, which was reversed by administration of 10 mg/kg
resveratrol. Additionally, it encumbered the tissue activation of Syk, PLCγ, and PKCμ in
antigen-exposed mice.
Resveratrol decreased
IgE-mediated PCA and alleviated allergic
edema of mouse ear and dorsal skin. Mast cell degranulation and allergic
inflammation, accompanying the induction of
monocyte chemotactic protein-1 and macrophage inflammatory protein-2, were inhibited by supplementing
resveratrol to
antigen-challenged mice.
Resveratrol inhibited mast cell-derived, immediate-type
allergic reactions, and these responses of
resveratrol suggest possible therapeutic strategies in preventing allergic inflammatory diseases.